샘플 요청 목록

 카트 문의
시장보고서
상품코드
1794715

세계의 육종 생검 시장

Sarcoma Biopsy
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 282 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

육종 생검 세계 시장은 2030년까지 2억 5,580만 달러에 달할 전망

2024년에 2억 2,950만 달러로 추정되는 육종 생검 세계 시장은 2030년에는 2억 5,580만 달러에 달하고, 분석 기간인 2024-2030년 CAGR은 1.8%로 성장할 것으로 예측됩니다. 재사용 가능 육종 생검 기기는 이 보고서에서 분석한 부문 중 하나로 CAGR은 1.4%를 기록하며 분석 기간 종료시에는 1억 6,250만 달러에 달할 것으로 예측됩니다. 일회용 육종 생검 기기 부문의 성장률은 분석 기간 동안 CAGR 2.6%로 추정됩니다.

미국 시장은 6,250만 달러로 추정, 중국은 CAGR 3.6%로 성장 예측

미국의 육종 생검 시장은 2024년에 6,250만 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 2030년까지 4,760만 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 3.6%를 기록할 것으로 예상됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 0.6%와 1.3%로 예측됩니다. 유럽에서는 독일이 CAGR 약 0.9%로 성장할 것으로 예측됩니다.

세계의 육종 생검 시장 - 주요 동향과 촉진요인 정리

육종 아형 관리에서 정확한 생검이 중요한 이유는 무엇인가?

육종은 간엽 조직에서 발생하는 희귀한 악성종양으로 치료 계획과 예후 평가의 지침이 되는 정확한 병리조직학적 진단이 요구되는 불균질한 그룹입니다. 골육종, 지방육종, 평활근육종, 활막육종 등 70여 가지 이상의 아형이 있으며, 정확한 생검은 양성 병변과 침습성 악성 종양을 감별하기 위한 기본입니다. 세침흡인(FNA), 중심침생검(CNB), 개복수술에 의한 생검이 주요 방법이며, 각각 종양의 위치, 크기, 의심되는 병리학적 소견에 따라 선택됩니다. 이 중 영상 유도하 CNB는 최소한의 이환율로 충분한 조직 샘플을 채취할 수 있어 초기 진단에 바람직한 방법입니다.

생검법의 선택은 진단 결과, 병기 분류의 정확성, 개별화 치료의 가능성에 직접적인 영향을 미칩니다. 생검이 부적절하게 시행된 경우, 특히 다학제적 검토 없이 시행된 경우, 종양의 파종, 부정확한 악성도 분류, 절제 단면의 손상으로 이어질 수 있습니다. 현재 육종 전문 센터에서는 종양 정형외과 전문의와 방사선과 전문의의 감독하에 생검을 의무화하여 최적의 시료 채취, 궤도 계획 및 생검 후 수술의 실행 가능성을 보장하고 있습니다. 많은 육종이 치료 결정에 영향을 미치는 명확한 유전자 융합이나 돌연변이(예: EWSR1, SYT-SSX)를 가지고 있기 때문에 분자생물학적 검사 및 세포유전학적 검사에서 생검의 중요성이 증가하고 있습니다. 그 결과, 생검 프로세스는 정밀 진단 및 차세대 시퀀서 워크플로우와 통합되고 있습니다.

육종 생검의 정확성과 유용성을 높이는 기술 혁신이란?

영상 진단과 분자진단의 기술적 발전은 육종 생검의 시행, 해석 및 임상적 의사결정에 활용되는 방식을 변화시키고 있습니다. MRI나 CT와 같은 고해상도 영상 진단 장비의 보급으로 괴사조직이나 섬유화 조직을 피하면서 생존 종양 부위를 보다 정확하게 표적화할 수 있게 되었습니다. 특히 초음파 유도하 CNB는 실시간 시각화와 시술의 효율성으로 인해 표재성 육종과 연부 육종에 대한 선호도가 높아지고 있습니다. 심재성 종양의 경우, 진단 능력을 향상시키고 합병증을 최소화하기 위해 CT 유도하 또는 투시하 생검이 종종 채택되고 있습니다.

디지털 병리학과 AI를 통한 조직 판독의 부상은 진단의 속도와 정확성을 가속화하고 있습니다. 이 플랫폼은 신속한 디지털 슬라이드 분석, 패턴 인식, 육종 전문의와의 실시간 상담을 가능하게 합니다. 또한, 형광 in situ hybridization(FISH), 역전사 중합효소 연쇄 반응(RT-PCR), 차세대 염기서열 분석(NGS)과 같은 분자 분석은 발암성 융합, 전좌, 실용적 돌연변이를 확인하기 위해 생검 검체에서 수행되고 있습니다. 육종에서는 아직 초기 단계이지만, 액체 생검은 질병 모니터링 및 미세 잔존 병변의 검출을 위해 조직 생검을 보완하는 비침습적 방법으로 연구되고 있습니다. 이러한 기술을 통해 육종 치료는 보다 개인화된 바이오마커 중심의 치료로 전환되고 있습니다.

육종 생검을 시행하는 임상 환경과 지역은?

육종 생검은 주로 종양학, 병리학, 병리학, 외과 전문팀이 있는 3차 의뢰센터에서 이루어집니다. 이들 센터는 고정밀 영상 유도 생검을 시행하고 종합적인 진단 프로파일링을 위한 분자 병리학 서비스를 통합할 수 있는 시설을 갖추고 있습니다. 북미와 서유럽에서는 중앙집중화된 육종 네트워크를 통해 프로토콜화된 워크플로우에 따라 생검을 실시하여 진단 오류를 최소화하고 치료의 연계성을 극대화하고 있습니다. 미국, 영국, 프랑스, 독일, 네덜란드가 중요한 거점이며, 종양위원회 내에서 다학제적 팀이 생검 계획을 세우고 진단 전략과 치료 방침의 일관성을 보장하고 있습니다.

신흥국에서는 생검을 시행하는 방법이 의료 인프라와 종양학 전문가에 대한 접근성에 따라 달라집니다. 도시 지역에서는 영상 유도하 CNB가 점점 더 많이 이용되고 있지만, 지방 병원에서는 진단 목적으로 외과적 절제술에 의존하는 경우가 많아 수술적 위험이 증가하고 치료가 지연됩니다. 하지만 종양내과 진료의 분산화와 영상 진단 장비에 대한 투자로 생검의 접근성은 점차 개선되고 있습니다. 생검 이용의 지역적 격차는 환자의 인식, 의료비 지원, 의뢰 경로에 따라 형성되기도 합니다. 아시아태평양 시장, 특히 일본, 한국, 인도에서는 분자진단의 통합이 진행되고 있으며, 라틴아메리카와 중동에서는 국제적인 암 네트워크 및 NGO와의 제휴를 통한 성장을 볼 수 있습니다.

육종 생검 세계 시장 성장을 촉진하는 요인은 무엇인가?

육종 생검 시장의 성장은 희귀하고 복잡한 육종의 발생률 증가, 영상 진단의 발전, 정밀 종양학의 채택 증가 등 여러 가지 상호 연관된 요인에 의해 주도되고 있습니다. 조기에 정확한 진단은 효과적인 육종 치료의 기초이며, 생검은 표적 치료 및 수술 계획의 입구 역할을 합니다. 다학제적 치료와 종양 관리의 일원화가 강조되면서 생검술은 임상적 선견지명을 가지고 시행되고 더 광범위한 종양학적 경로에 통합되고 있습니다. 영상 진단, 생검침 디자인, 분자검사의 기술적 개선은 진단 수율, 환자 안전, 소요시간을 개선하고 있습니다.

암에 대한 인식의 증가, 의료 인프라의 확대, 육종 등록의 급증도 생검 서비스에 대한 수요를 가속화하고 있습니다. 생검 샘플의 유용성은 조직학에 국한되지 않고 유전체학, 단백질체학, 면역항원형성까지 확대되어 병리검사실과 진단기기 제조업체에 새로운 가치의 흐름을 만들어내고 있습니다. 희귀암 연구에 대한 규제 당국의 지원은 육종에 초점을 맞춘 임상시험에 대한 투자 증가와 함께 시장 활성화를 더욱 촉진하고 있습니다. 또한, 영상의학과 전문의와 병리학자를 대상으로 한 교육 이니셔티브는 자원이 부족한 환경에서 역량을 강화하는 데 기여하고 있습니다. 이러한 움직임을 종합하면, 육종 진료의 발전에 있어 진단의 핵심인 생검의 역할이 강화되고 있습니다.

부문

제품 유형(재이용형 육종 생검 기기, 일회용 육종 생검 기기), 최종사용자(병원 최종사용자, 외래 수술 센터 최종사용자, 진단 센터 최종사용자)

조사 대상 기업 사례

  • Abbott Laboratories
  • Agilent Technologies Inc.
  • ANGLE plc
  • Argon Medical Devices
  • Becton, Dickinson and Company(BD)
  • Biocept, Inc.
  • Bio-Rad Laboratories, Inc.
  • Boston Scientific Corporation
  • Cardinal Health Inc.
  • Cook Medical Incorporated
  • Danaher Corporation
  • Exact Sciences Corporation
  • F. Hoffmann-La Roche Ltd.
  • GRAIL, Inc.
  • Guardant Health
  • Hologic, Inc.
  • Illumina, Inc.
  • Medtronic plc
  • Myriad Genetics, Inc.
  • QIAGEN N.V.
  • Siemens Healthineers
  • Sterylab S.r.l.
  • Thermo Fisher Scientific Inc.
  • UROMED

AI 통합

Global Industry Analysts는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 일반적인 LLM 및 업계별 SLM 쿼리를 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSM 25.08.28

Global Sarcoma Biopsy Market to Reach US$255.8 Million by 2030

The global market for Sarcoma Biopsy estimated at US$229.5 Million in the year 2024, is expected to reach US$255.8 Million by 2030, growing at a CAGR of 1.8% over the analysis period 2024-2030. Reusable Sarcoma Biopsy Devices, one of the segments analyzed in the report, is expected to record a 1.4% CAGR and reach US$162.5 Million by the end of the analysis period. Growth in the Disposable Sarcoma Biopsy Devices segment is estimated at 2.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$62.5 Million While China is Forecast to Grow at 3.6% CAGR

The Sarcoma Biopsy market in the U.S. is estimated at US$62.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$47.6 Million by the year 2030 trailing a CAGR of 3.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.6% and 1.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 0.9% CAGR.

Global Sarcoma Biopsy Market - Key Trends & Drivers Summarized

Why Is Accurate Biopsy Critical in the Management of Sarcoma Subtypes?

Sarcomas, a heterogeneous group of rare malignant tumors arising from mesenchymal tissues, demand precise histopathological diagnosis to guide treatment planning and prognostic assessment. With over 70 distinct subtypes-including osteosarcoma, liposarcoma, leiomyosarcoma, and synovial sarcoma-accurate biopsy is fundamental to differentiating benign lesions from aggressive malignancies. Fine-needle aspiration (FNA), core needle biopsy (CNB), and open surgical biopsies are the primary methods used, each selected based on tumor location, size, and suspected pathology. Among these, image-guided CNB has become the preferred modality for initial diagnosis due to its ability to retrieve sufficient tissue samples with minimal morbidity.

The choice of biopsy technique directly influences diagnostic yield, staging accuracy, and the feasibility of personalized treatment. Biopsies that are improperly performed-particularly without multidisciplinary input-can lead to tumor seeding, inaccurate grading, or compromised resection margins. Specialized sarcoma centers now mandate biopsy under the supervision of oncologic orthopedic surgeons and radiologists to ensure optimal sample collection, trajectory planning, and post-biopsy surgical feasibility. The importance of biopsy in molecular and cytogenetic testing is also increasing, as many sarcomas harbor distinct gene fusions or mutations (e.g., EWSR1, SYT-SSX) that impact therapeutic decisions. As a result, the biopsy process is becoming more integrated with precision diagnostics and next-generation sequencing workflows.

What Technological Innovations Are Advancing the Accuracy and Utility of Sarcoma Biopsies?

Technological advancements in imaging and molecular diagnostics are transforming the way sarcoma biopsies are performed, interpreted, and utilized for clinical decision-making. The widespread use of high-resolution imaging modalities-such as MRI and CT-enables more accurate targeting of viable tumor regions while avoiding necrotic or fibrotic tissue. Ultrasound-guided CNB, in particular, is gaining favor for superficial and soft-tissue sarcomas due to real-time visualization and procedural efficiency. In deep-seated tumors, CT-guided or fluoroscopy-assisted biopsy is often employed to improve diagnostic yield and minimize complications.

The rise of digital pathology and AI-assisted histological interpretation is accelerating the speed and precision of diagnosis. These platforms enable rapid digital slide analysis, pattern recognition, and real-time consultation with sarcoma specialists. Additionally, molecular assays-such as fluorescence in situ hybridization (FISH), reverse transcription polymerase chain reaction (RT-PCR), and next-generation sequencing (NGS)-are increasingly performed on biopsy specimens to identify oncogenic fusions, translocations, and actionable mutations. Liquid biopsy, though still in its early stages for sarcomas, is being explored as a non-invasive complement to tissue biopsy for disease monitoring and minimal residual disease detection. These technological enablers are facilitating a shift toward more individualized and biomarker-driven sarcoma treatment pathways.

Which Clinical Settings and Geographies Are Shaping Sarcoma Biopsy Practices?

Sarcoma biopsies are predominantly conducted in tertiary referral centers with dedicated oncology, pathology, and surgical teams. These centers are equipped to perform high-precision, image-guided biopsies and integrate molecular pathology services for comprehensive diagnostic profiling. In North America and Western Europe, centralized sarcoma networks ensure that biopsies are performed under protocolized workflows, minimizing diagnostic errors and maximizing treatment coordination. The U.S., U.K., France, Germany, and the Netherlands are key hubs where multidisciplinary teams conduct biopsy planning within tumor boards, ensuring alignment between diagnostic strategy and therapeutic trajectory.

In emerging economies, biopsy practices vary based on healthcare infrastructure and access to oncologic expertise. While image-guided CNB is increasingly available in urban centers, rural hospitals often rely on surgical excision for diagnostic purposes, increasing procedural risks and delaying treatment. However, initiatives to decentralize oncology services and invest in diagnostic imaging equipment are gradually improving biopsy accessibility. Regional disparities in biopsy utilization are also shaped by patient awareness, healthcare funding, and referral pathways. Asia-Pacific markets, particularly Japan, South Korea, and India, are making strides in molecular diagnostic integration, while Latin America and the Middle East are seeing growth through partnerships with international cancer networks and NGOs.

What Factors Are Driving Growth in the Global Sarcoma Biopsy Market?

The growth in the sarcoma biopsy market is driven by several interrelated factors, including the increasing incidence of rare and complex sarcomas, advancements in diagnostic imaging, and the rising adoption of precision oncology. Early and accurate diagnosis remains the cornerstone of effective sarcoma treatment, with biopsy serving as the gateway to targeted therapy and surgical planning. The growing emphasis on multidisciplinary care and centralized tumor management is ensuring that biopsy procedures are performed with clinical foresight and integrated into broader oncology pathways. Technological improvements in imaging, biopsy needle design, and molecular testing are improving diagnostic yield, patient safety, and turnaround times.

Rising cancer awareness, expanding healthcare infrastructure, and the proliferation of sarcoma registries are also accelerating demand for biopsy services. Biopsy sample utility has extended beyond histology to encompass genomics, proteomics, and immunophenotyping, creating new value streams for pathology labs and diagnostic device manufacturers. Regulatory support for rare cancer research, along with increased investment in sarcoma-focused clinical trials, is further boosting market activity. Additionally, training initiatives aimed at radiologists and pathologists are building capacity in under-resourced settings. Collectively, these dynamics are reinforcing the role of biopsy as a diagnostic linchpin in the evolving landscape of sarcoma care.

SCOPE OF STUDY:

The report analyzes the Sarcoma Biopsy market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Reusable Sarcoma Biopsy Devices, Disposable Sarcoma Biopsy Devices); End-Use (Hospitals End-Use, Ambulatory Surgery Centers End-Use, Diagnostic Centers End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 48 Featured) -

  • Abbott Laboratories
  • Agilent Technologies Inc.
  • ANGLE plc
  • Argon Medical Devices
  • Becton, Dickinson and Company (BD)
  • Biocept, Inc.
  • Bio-Rad Laboratories, Inc.
  • Boston Scientific Corporation
  • Cardinal Health Inc.
  • Cook Medical Incorporated
  • Danaher Corporation
  • Exact Sciences Corporation
  • F. Hoffmann-La Roche Ltd.
  • GRAIL, Inc.
  • Guardant Health
  • Hologic, Inc.
  • Illumina, Inc.
  • Medtronic plc
  • Myriad Genetics, Inc.
  • QIAGEN N.V.
  • Siemens Healthineers
  • Sterylab S.r.l.
  • Thermo Fisher Scientific Inc.
  • UROMED

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Sarcoma Biopsy - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Soft Tissue and Bone Sarcomas Spurs Growth in Biopsy-Based Diagnostics
    • Increased Emphasis on Early and Accurate Diagnosis Strengthens Business Case for Advanced Biopsy Methods
    • Growth in Image-Guided Biopsy Techniques Enhances Precision and Diagnostic Yield in Sarcoma Cases
    • Adoption of Minimally Invasive Biopsy Approaches Expands Patient Comfort and Compliance
    • Expansion of Tumor Genotyping and Molecular Profiling Drives Demand for High-Quality Biopsy Samples
    • Integration of Liquid Biopsy and Circulating Tumor DNA Analysis Expands Non-Invasive Diagnostic Options
    • Clinical Need for Histopathological Subtyping Fuels Demand for Core Needle and Open Biopsies
    • Rising Awareness of Misdiagnosis in Rare Sarcoma Subtypes Propels Demand for Biopsy Re-Evaluation
    • Growth in Multidisciplinary Sarcoma Centers Strengthens Standardization of Biopsy Protocols
    • Advances in Biomarker Discovery and Tissue Analysis Enhance Biopsy-Driven Research
    • Increasing Demand for Biobanked Sarcoma Tissue Expands Role of Biopsy in Translational Medicine
    • Development of AI-Based Histology Interpretation Tools Accelerates Biopsy Result Turnaround
    • Growth in Personalized Oncology and Targeted Therapies Drives Re-Biopsy at Progression or Recurrence
    • Surge in Clinical Trials for Rare Sarcomas Generates Consistent Demand for Diagnostic Tissue Acquisition
    • Integration of Molecular Pathology in Biopsy Analysis Expands Scope Beyond Morphology
    • Digital Workflow and Cloud-Based Pathology Tools Improve Biopsy Sample Sharing Across Institutions
    • Expansion of Multisite Hospital Networks Fuels Centralized Biopsy Services for Sarcoma Diagnosis
    • Collaborations Between Academic Hospitals and Oncology Biotech Firms Enhance Sample Access
    • Regulatory Push for Diagnostic Standardization in Oncology Improves Biopsy Reporting Quality
    • Increased Emphasis on Quality Control and Accreditation of Biopsy Labs Drives Institutional Investment
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Sarcoma Biopsy Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Sarcoma Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Sarcoma Biopsy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Sarcoma Biopsy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Reusable Sarcoma Biopsy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Reusable Sarcoma Biopsy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Reusable Sarcoma Biopsy Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Disposable Sarcoma Biopsy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Disposable Sarcoma Biopsy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Disposable Sarcoma Biopsy Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Ambulatory Surgery Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Ambulatory Surgery Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Diagnostic Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Sarcoma Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Sarcoma Biopsy by Product Type - Percentage Breakdown of Value Sales for Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices for the Years 2014, 2025 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Sarcoma Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Sarcoma Biopsy by Product Type - Percentage Breakdown of Value Sales for Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices for the Years 2014, 2025 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Sarcoma Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use for the Years 2014, 2025 & 2030
  • JAPAN
    • Sarcoma Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Sarcoma Biopsy by Product Type - Percentage Breakdown of Value Sales for Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices for the Years 2014, 2025 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Sarcoma Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use for the Years 2014, 2025 & 2030
  • CHINA
    • Sarcoma Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 40: China 16-Year Perspective for Sarcoma Biopsy by Product Type - Percentage Breakdown of Value Sales for Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices for the Years 2014, 2025 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 43: China 16-Year Perspective for Sarcoma Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use for the Years 2014, 2025 & 2030
  • EUROPE
    • Sarcoma Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Sarcoma Biopsy by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Sarcoma Biopsy by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Sarcoma Biopsy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Sarcoma Biopsy by Product Type - Percentage Breakdown of Value Sales for Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices for the Years 2014, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Sarcoma Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use for the Years 2014, 2025 & 2030
  • FRANCE
    • Sarcoma Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 55: France 16-Year Perspective for Sarcoma Biopsy by Product Type - Percentage Breakdown of Value Sales for Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices for the Years 2014, 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 58: France 16-Year Perspective for Sarcoma Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use for the Years 2014, 2025 & 2030
  • GERMANY
    • Sarcoma Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Sarcoma Biopsy by Product Type - Percentage Breakdown of Value Sales for Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices for the Years 2014, 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Sarcoma Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Sarcoma Biopsy by Product Type - Percentage Breakdown of Value Sales for Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices for the Years 2014, 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Sarcoma Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Sarcoma Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Sarcoma Biopsy by Product Type - Percentage Breakdown of Value Sales for Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices for the Years 2014, 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Sarcoma Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 79: Spain 16-Year Perspective for Sarcoma Biopsy by Product Type - Percentage Breakdown of Value Sales for Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices for the Years 2014, 2025 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Sarcoma Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 85: Russia 16-Year Perspective for Sarcoma Biopsy by Product Type - Percentage Breakdown of Value Sales for Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices for the Years 2014, 2025 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Sarcoma Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Sarcoma Biopsy by Product Type - Percentage Breakdown of Value Sales for Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices for the Years 2014, 2025 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Sarcoma Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Sarcoma Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Sarcoma Biopsy by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Sarcoma Biopsy by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Sarcoma Biopsy by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Sarcoma Biopsy by Product Type - Percentage Breakdown of Value Sales for Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices for the Years 2014, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Sarcoma Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Sarcoma Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 106: Australia 16-Year Perspective for Sarcoma Biopsy by Product Type - Percentage Breakdown of Value Sales for Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices for the Years 2014, 2025 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Sarcoma Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use for the Years 2014, 2025 & 2030
  • INDIA
    • Sarcoma Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 112: India 16-Year Perspective for Sarcoma Biopsy by Product Type - Percentage Breakdown of Value Sales for Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices for the Years 2014, 2025 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 115: India 16-Year Perspective for Sarcoma Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 118: South Korea 16-Year Perspective for Sarcoma Biopsy by Product Type - Percentage Breakdown of Value Sales for Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices for the Years 2014, 2025 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Sarcoma Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Sarcoma Biopsy by Product Type - Percentage Breakdown of Value Sales for Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices for the Years 2014, 2025 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Sarcoma Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Sarcoma Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Sarcoma Biopsy by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Sarcoma Biopsy by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 130: Latin America 16-Year Perspective for Sarcoma Biopsy by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Sarcoma Biopsy by Product Type - Percentage Breakdown of Value Sales for Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices for the Years 2014, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Sarcoma Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 139: Argentina 16-Year Perspective for Sarcoma Biopsy by Product Type - Percentage Breakdown of Value Sales for Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices for the Years 2014, 2025 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Sarcoma Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 145: Brazil 16-Year Perspective for Sarcoma Biopsy by Product Type - Percentage Breakdown of Value Sales for Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices for the Years 2014, 2025 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Sarcoma Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 151: Mexico 16-Year Perspective for Sarcoma Biopsy by Product Type - Percentage Breakdown of Value Sales for Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices for the Years 2014, 2025 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Sarcoma Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 157: Rest of Latin America 16-Year Perspective for Sarcoma Biopsy by Product Type - Percentage Breakdown of Value Sales for Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices for the Years 2014, 2025 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Sarcoma Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Sarcoma Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Sarcoma Biopsy by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Sarcoma Biopsy by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 163: Middle East 16-Year Perspective for Sarcoma Biopsy by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Sarcoma Biopsy by Product Type - Percentage Breakdown of Value Sales for Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices for the Years 2014, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Sarcoma Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 172: Iran 16-Year Perspective for Sarcoma Biopsy by Product Type - Percentage Breakdown of Value Sales for Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices for the Years 2014, 2025 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Sarcoma Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 178: Israel 16-Year Perspective for Sarcoma Biopsy by Product Type - Percentage Breakdown of Value Sales for Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices for the Years 2014, 2025 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Sarcoma Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 184: Saudi Arabia 16-Year Perspective for Sarcoma Biopsy by Product Type - Percentage Breakdown of Value Sales for Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices for the Years 2014, 2025 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Sarcoma Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 190: UAE 16-Year Perspective for Sarcoma Biopsy by Product Type - Percentage Breakdown of Value Sales for Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices for the Years 2014, 2025 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Sarcoma Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 196: Rest of Middle East 16-Year Perspective for Sarcoma Biopsy by Product Type - Percentage Breakdown of Value Sales for Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices for the Years 2014, 2025 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Sarcoma Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use for the Years 2014, 2025 & 2030
  • AFRICA
    • Sarcoma Biopsy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Sarcoma Biopsy by Product Type - Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 202: Africa 16-Year Perspective for Sarcoma Biopsy by Product Type - Percentage Breakdown of Value Sales for Reusable Sarcoma Biopsy Devices and Disposable Sarcoma Biopsy Devices for the Years 2014, 2025 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Sarcoma Biopsy by End-Use - Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Sarcoma Biopsy by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ambulatory Surgery Centers End-Use and Diagnostic Centers End-Use for the Years 2014, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제